1441 related articles for article (PubMed ID: 19651676)
21. Primary renal artery stenting: characteristics and outcomes after 363 procedures.
Lederman RJ; Mendelsohn FO; Santos R; Phillips HR; Stack RS; Crowley JJ
Am Heart J; 2001 Aug; 142(2):314-23. PubMed ID: 11479472
[TBL] [Abstract][Full Text] [Related]
22. Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT Trial): angiographic follow-up after 6 months and clinical outcome up to 2 years.
Zähringer M; Sapoval M; Pattynama PM; Rabbia C; Vignali C; Maleux G; Boyer L; Szczerbo-Trojanowska M; Jaschke W; Hafsahl G; Downes M; Bérégi JP; Veeger NJ; Stoll HP; Talen A
J Endovasc Ther; 2007 Aug; 14(4):460-8. PubMed ID: 17696619
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of endoluminal reintervention for restenosis after percutaneous renal angioplasty and stenting.
Davies MG; Saad WA; Bismuth JX; Peden EK; Naoum JJ; Lumsden AB
J Vasc Surg; 2009 Apr; 49(4):946-52. PubMed ID: 19217748
[TBL] [Abstract][Full Text] [Related]
24. Low-profile stent placement with the monorail technique for treatment of renal artery stenosis: midterm results of a prospective trial.
Müller-Hülsbeck S; Frahm C; Behm C; Schäfer PJ; Bolte H; Heller M; Jahnke T
J Vasc Interv Radiol; 2005 Jul; 16(7):963-71. PubMed ID: 16002504
[TBL] [Abstract][Full Text] [Related]
25. Percutaneous vascular interventions in renal artery diseases.
Kolluri R; Goldstein JA; Rocha-Singh K
Minerva Cardioangiol; 2006 Feb; 54(1):95-107. PubMed ID: 16467745
[TBL] [Abstract][Full Text] [Related]
26. Endovascular therapy of renovascular hypertension in children: single center analysis.
Radanović B; Cacić Z; Perkov D; Smiljanić R; Corić SR; Ilakovac K
Eur J Pediatr Surg; 2009 Jun; 19(3):135-40. PubMed ID: 19360546
[TBL] [Abstract][Full Text] [Related]
27. First use of cryoplasty to treat in-stent renal artery restenosis.
Jefferies JL; Dougherty K; Krajcer Z
Tex Heart Inst J; 2008; 35(3):352-5. PubMed ID: 18941646
[TBL] [Abstract][Full Text] [Related]
28. How to treat recurrent renal artery instent restenosis? Editorial comment on treatment of reoccuring instent restenosis following reintervention after stent-supported renal artery angioplasty--article by Zeller et al.
Schillinger M
Catheter Cardiovasc Interv; 2007 Aug; 70(2):301-2. PubMed ID: 17630675
[No Abstract] [Full Text] [Related]
29. Treatment of renal artery fibromuscular dysplasia with balloon angioplasty: a prospective follow-up study.
Birrer M; Do DD; Mahler F; Triller J; Baumgartner I
Eur J Vasc Endovasc Surg; 2002 Feb; 23(2):146-52. PubMed ID: 11863332
[TBL] [Abstract][Full Text] [Related]
30. Renal angioplasty and stenting under protection: the way for the future?
Henry M; Henry I; Klonaris C; Polydorou A; Rath P; Lakshmi G; Rajacopal S; Hugel M
Catheter Cardiovasc Interv; 2003 Nov; 60(3):299-312. PubMed ID: 14571477
[TBL] [Abstract][Full Text] [Related]
31. Three-dimensional balloon catheter sizing identifies significant underdeployed stents using conventional methods in renal artery interventions.
Aqel RA; Zoghbi GJ; Hage FG; Dell'Italia L
J Invasive Cardiol; 2008 Jun; 20(6):270-6. PubMed ID: 18523318
[TBL] [Abstract][Full Text] [Related]
32. The use of brachytherapy to treat renal artery in-stent restenosis.
Ellis K; Murtagh B; Loghin C; Muench A; Boccalandro F; Go B; Ahmad M; Burjonroppa S; Rosales O; Smalling RW
J Interv Cardiol; 2005 Feb; 18(1):49-54. PubMed ID: 15788055
[TBL] [Abstract][Full Text] [Related]
33. Renal artery PTA and stent implantation: immediate and late clinical and morphological outcome.
Ahmadi R; Schillinger M; Sabeti S; Loewe C; Mlekusch W; Haumer M; Banyai M; Lammer J; Minar E
Wien Klin Wochenschr; 2002 Jan; 114(1-2):21-7. PubMed ID: 12407931
[TBL] [Abstract][Full Text] [Related]
34. Restenosis following percutaneous renal artery revascularization.
Kane GC; Hambly N; Textor SC; Stanson AW; Garovic VD
Nephron Clin Pract; 2007; 107(2):c63-9. PubMed ID: 17848809
[TBL] [Abstract][Full Text] [Related]
35. Drug-eluting stents versus bare metal stents for the prevention of restenosis in patients with renovascular disease.
Bradaric C; Eser K; Preuss S; Dommasch M; Wustrow I; Langwieser N; Haller B; Ott I; Fusaro M; Heemann U; Laugwitz KL; Kastrati A; Ibrahim T
EuroIntervention; 2017 Jun; 13(2):e248-e255. PubMed ID: 28044987
[TBL] [Abstract][Full Text] [Related]
36. Recalcitrant in-stent restenosis of the celiac trunk treated by drug-eluting stent.
Visconti G; Taranto D; Briguori C
Catheter Cardiovasc Interv; 2008 Nov; 72(6):873-6. PubMed ID: 19009632
[TBL] [Abstract][Full Text] [Related]
37. Acute renal artery stent thrombosis with a solitary functioning kidney.
Torre J; Hashisho M; Lo C; Mohan E
Ann Vasc Surg; 2010 Oct; 24(7):953.e13-9. PubMed ID: 20598850
[TBL] [Abstract][Full Text] [Related]
38. Short- and long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over a ten-year period.
Mousa AY; Campbell JE; Stone PA; Broce M; Bates MC; AbuRahma AF
J Vasc Surg; 2012 Feb; 55(2):421-7. PubMed ID: 22112553
[TBL] [Abstract][Full Text] [Related]
39. Renovascular hypertension: diagnostic and therapeutic challenges.
Bosmans JL; De Broe ME
JBR-BTR; 2004; 87(1):32-5. PubMed ID: 15055332
[TBL] [Abstract][Full Text] [Related]
40. Treatment of renal artery in-stent restenosis with sirolimus-eluting stents.
Kiernan TJ; Yan BP; Eisenberg JD; Ruggiero NJ; Gupta V; Drachman D; Schainfeld RM; Jaff MR; Rosenfield K; Garasic J
Vasc Med; 2010 Feb; 15(1):3-7. PubMed ID: 19793778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]